The ACR is offering new tools to help radiology practices evaluate and monitor imaging AI algorithms.
Key Details
- 1The American College of Radiology is expanding its suite of resources for radiology practices evaluating imaging AI.
- 2A repository now compiles all FDA-cleared, pixel-based AI algorithms for member review.
- 3Over 1,400 clinical algorithms have FDA clearance, with 80% targeting medical imaging.
- 4Hundreds of vendors offer both FDA-cleared and non-regulated imaging AI products.
- 5ACR aims to help radiologists make informed purchasing and adoption decisions given the complexity of the AI landscape.
Why It Matters
As the AI market for medical imaging becomes increasingly crowded, these centralized resources are critical to help radiology practices select safe, effective tools and keep up with rapid advancements. Such efforts by the ACR can drive informed, evidence-based adoption of AI in clinical practice.
Source
Radiology Business
Related News
•HealthExec
AI Reimbursement, Biomedical Research, and Exec Survey Highlight Healthcare Trends
Healthcare AI adoption is rising, but ROI measurement and clinical impact remain key challenges.
•HealthExec
Senate Vote Fails to Block AI Medicare Prior Authorization Pilot
A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
•AuntMinnie
Radiology Leads FDA AI Device Approvals Over Three Decades
Radiology accounts for 76% of all FDA-cleared AI/ML-enabled medical devices as of the end of 2025.